ARCHIVES OF GYNECOLOGY AND OBSTETRICS, vol.292, no.1, pp.209-216, 2015 (SCI-Expanded)
Purpose The aim of this study was to test if melatonin causes regression of endometriotic implants and whether it influences implant levels of superoxide dismutase (SOD), malondialdehyde (MDA), vascular endothelial growth factor (VEGF), tissue inhibitor of metalloproteinase (TIMP)-2 and matrix metalloproteinase (MMP)-9 in rats.